Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 1 | -$0.05 | -$0.04 | -$0.04 |
Q2 2024 | 1 | $0.02 | $0.02 | $0.02 |
Q3 2024 | 1 | -$0.01 | -$0.01 | -$0.01 |
Q4 2024 | 2 | $0.11 | $0.13 | $0.12 |
Q1 2025 | 2 | $0.11 | $0.13 | $0.12 |
Q2 2025 | 1 | $0.12 | $0.15 | $0.14 |
Q3 2025 | 1 | $0.12 | $0.15 | $0.14 |
Q4 2025 | 1 | $0.23 | $0.28 | $0.26 |
Q1 2026 | 1 | $0.05 | $0.06 | $0.06 |
Q2 2026 | 1 | $0.09 | $0.11 | $0.10 |
Q3 2026 | 1 | $0.05 | $0.06 | $0.06 |
Q4 2026 | 1 | $0.13 | $0.15 | $0.14 |
Sensus Healthcare, Inc. last posted its earnings results on Thursday, November 14th, 2024. The company reported $0.07 earnings per share for the quarter, topping analysts' consensus estimates of $0.00778 by $0.06222. The company had revenue of 8.84 M for the quarter and had revenue of 24.41 M for the year. Sensus Healthcare, Inc. has generated $0 earnings per share over the last year ($0.0298 diluted earnings per share) and currently has a price-to-earnings ratio of 12.45. Sensus Healthcare, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 6th, 2025 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
11/14/2024 | Q3 2024 | $0.01 | $0.07 | 0.07 | $5.90 M | $8.84 M |
08/13/2024 | Q2 2024 | $0.10 | $7.00 M | $9.24 M | ||
05/10/2024 | Q1 2024 | $0.14 | $10.66 M | |||
03/15/2024 | Q4 2023 | $0.26 | $12.57 M | |||
11/13/2023 | Q3 2023 | -$0.09 | $5.90 M | $3.90 M | ||
08/11/2023 | Q2 2023 | -$0.02 | $4.55 M | $4.53 M | ||
05/12/2023 | Q1 2023 | -$0.12 | $3.41 M | |||
03/23/2023 | Q4 2022 | $0.17 | $13.11 M | |||
11/10/2022 | Q3 2022 | $0.11 | $9.54 M | $9.01 M | ||
08/12/2022 | Q2 2022 | $0.21 | $9.56 M | $12.08 M | ||
05/12/2022 | Q1 2022 | $0.97 | $10.34 M | |||
03/25/2022 | Q4 2021 | $0.32 | $13.03 M | |||
11/10/2021 | Q3 2021 | $0.01 | $5.40 M | $5.53 M | ||
08/13/2021 | Q2 2021 | -$0.02 | $4.28 M | $5.42 M | ||
05/14/2021 | Q1 2021 | -$0.07 | $3.07 M | |||
03/05/2021 | Q4 2020 | $0.06 | $5.09 M | |||
11/10/2020 | Q3 2020 | -$0.10 | $2.04 M | $1.62 M | ||
08/10/2020 | Q2 2020 | -$0.16 | $1.44 M | $1.18 M | ||
05/11/2020 | Q1 2020 | -$0.22 | $1.68 M | |||
03/06/2020 | Q4 2019 | $0.06 | $8.51 M |
Sensus Healthcare, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 6th, 2025 based off last year's report dates.
In the previous quarter, Sensus Healthcare, Inc. (:SRTS) reported $0.07 earnings per share (EPS) to beat the analysts' consensus estimate of $0.00778 by $0.06222.
The conference call for Sensus Healthcare, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Sensus Healthcare, Inc.'s latest earnings report can be read online.
Sensus Healthcare, Inc. (:SRTS) has a recorded annual revenue of $24.41 M.
Sensus Healthcare, Inc. (:SRTS) has a recorded net income of $24.41 M. Sensus Healthcare, Inc. has generated $0.0298 earnings per share over the last four quarters.
Sensus Healthcare, Inc. (:SRTS) has a price-to-earnings ratio of 12.45 and price/earnings-to-growth ratio is 0.32.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED